Press
Genesis Molecular AI Unveils Pearl
Genesis’ proprietary foundation model – Pearl – outperforms frontier models, including AlphaFold 3, on key benchmarks that predict utility in...
Read More →
Blog
Introducing Pearl: The Next Generation Foundation Model for Drug Discovery
First Model to Clearly Surpass AlphaFold 3 on Protein-Ligand Structure Prediction Your browser does not support the video tag. Why...
Read More →
Press
Incyte and Genesis Therapeutics Announce Strategic AI-focused Research Collaboration
Incyte and Genesis will leverage Genesis’ GEMS artificial intelligence (AI) platform to unlock the discovery of breakthrough small molecule therapeutics...
Read More →